Improving immune-vascular crosstalk for cancer immunotherapy

Yuhui Huang, Betty Y.S. Kim, Charles K. Chan, Stephen M. Hahn, Irving L. Weissman, Wen Jiang

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

The vasculature of tumours is highly abnormal and dysfunctional. Consequently, immune effector cells have an impaired ability to penetrate solid tumours and often exhibit compromised functions. Normalization of the tumour vasculature can enhance tissue perfusion and improve immune effector cell infiltration, leading to immunotherapy potentiation. However, recent studies have demonstrated that the stimulation of immune cell functions can also help to normalize tumour vessels. In this Opinion article, we propose that the reciprocal regulation between tumour vascular normalization and immune reprogramming forms a reinforcing loop that reconditions the tumour immune microenvironment to induce durable antitumour immunity. A deeper understanding of these pathways could pave the way for identifying new biomarkers and developing more effective combination treatment strategies for patients with cancer.

Original languageEnglish (US)
Pages (from-to)195-203
Number of pages9
JournalNature Reviews Immunology
Volume18
Issue number3
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Immunotherapy
Blood Vessels
Neoplasms
Tumor Microenvironment
Immunity
Perfusion
Biomarkers

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Huang, Y., Kim, B. Y. S., Chan, C. K., Hahn, S. M., Weissman, I. L., & Jiang, W. (2018). Improving immune-vascular crosstalk for cancer immunotherapy. Nature Reviews Immunology, 18(3), 195-203. https://doi.org/10.1038/nri.2017.145

Improving immune-vascular crosstalk for cancer immunotherapy. / Huang, Yuhui; Kim, Betty Y.S.; Chan, Charles K.; Hahn, Stephen M.; Weissman, Irving L.; Jiang, Wen.

In: Nature Reviews Immunology, Vol. 18, No. 3, 01.03.2018, p. 195-203.

Research output: Contribution to journalReview article

Huang, Y, Kim, BYS, Chan, CK, Hahn, SM, Weissman, IL & Jiang, W 2018, 'Improving immune-vascular crosstalk for cancer immunotherapy', Nature Reviews Immunology, vol. 18, no. 3, pp. 195-203. https://doi.org/10.1038/nri.2017.145
Huang, Yuhui ; Kim, Betty Y.S. ; Chan, Charles K. ; Hahn, Stephen M. ; Weissman, Irving L. ; Jiang, Wen. / Improving immune-vascular crosstalk for cancer immunotherapy. In: Nature Reviews Immunology. 2018 ; Vol. 18, No. 3. pp. 195-203.
@article{aba4e689dca54f1a878d533b724b0a76,
title = "Improving immune-vascular crosstalk for cancer immunotherapy",
abstract = "The vasculature of tumours is highly abnormal and dysfunctional. Consequently, immune effector cells have an impaired ability to penetrate solid tumours and often exhibit compromised functions. Normalization of the tumour vasculature can enhance tissue perfusion and improve immune effector cell infiltration, leading to immunotherapy potentiation. However, recent studies have demonstrated that the stimulation of immune cell functions can also help to normalize tumour vessels. In this Opinion article, we propose that the reciprocal regulation between tumour vascular normalization and immune reprogramming forms a reinforcing loop that reconditions the tumour immune microenvironment to induce durable antitumour immunity. A deeper understanding of these pathways could pave the way for identifying new biomarkers and developing more effective combination treatment strategies for patients with cancer.",
author = "Yuhui Huang and Kim, {Betty Y.S.} and Chan, {Charles K.} and Hahn, {Stephen M.} and Weissman, {Irving L.} and Wen Jiang",
year = "2018",
month = "3",
day = "1",
doi = "10.1038/nri.2017.145",
language = "English (US)",
volume = "18",
pages = "195--203",
journal = "Nature Reviews Immunology",
issn = "1474-1733",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Improving immune-vascular crosstalk for cancer immunotherapy

AU - Huang, Yuhui

AU - Kim, Betty Y.S.

AU - Chan, Charles K.

AU - Hahn, Stephen M.

AU - Weissman, Irving L.

AU - Jiang, Wen

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The vasculature of tumours is highly abnormal and dysfunctional. Consequently, immune effector cells have an impaired ability to penetrate solid tumours and often exhibit compromised functions. Normalization of the tumour vasculature can enhance tissue perfusion and improve immune effector cell infiltration, leading to immunotherapy potentiation. However, recent studies have demonstrated that the stimulation of immune cell functions can also help to normalize tumour vessels. In this Opinion article, we propose that the reciprocal regulation between tumour vascular normalization and immune reprogramming forms a reinforcing loop that reconditions the tumour immune microenvironment to induce durable antitumour immunity. A deeper understanding of these pathways could pave the way for identifying new biomarkers and developing more effective combination treatment strategies for patients with cancer.

AB - The vasculature of tumours is highly abnormal and dysfunctional. Consequently, immune effector cells have an impaired ability to penetrate solid tumours and often exhibit compromised functions. Normalization of the tumour vasculature can enhance tissue perfusion and improve immune effector cell infiltration, leading to immunotherapy potentiation. However, recent studies have demonstrated that the stimulation of immune cell functions can also help to normalize tumour vessels. In this Opinion article, we propose that the reciprocal regulation between tumour vascular normalization and immune reprogramming forms a reinforcing loop that reconditions the tumour immune microenvironment to induce durable antitumour immunity. A deeper understanding of these pathways could pave the way for identifying new biomarkers and developing more effective combination treatment strategies for patients with cancer.

UR - http://www.scopus.com/inward/record.url?scp=85042584062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042584062&partnerID=8YFLogxK

U2 - 10.1038/nri.2017.145

DO - 10.1038/nri.2017.145

M3 - Review article

C2 - 29332937

AN - SCOPUS:85042584062

VL - 18

SP - 195

EP - 203

JO - Nature Reviews Immunology

JF - Nature Reviews Immunology

SN - 1474-1733

IS - 3

ER -